申请人:Mochida Pharmaceutical Co., Ltd.
公开号:US05438139A1
公开(公告)日:1995-08-01
Acridinium compounds represented by the general formula (I) where A is an intervening group which does not have activity for binding with a specific binding substance, Z is a labelling active group which has activity for binding with a specific binding substance, R.sup.1 is a halogen atom, an alkyl group or an aryl group; R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are each a hydrogen atom, an alkyl group, an aryl group, an alkoxy group, a nitro group, a halogen atom or a carbonyl group, and Y is a counter ion. The acridinium compounds may form conjugates with specific binding substances. The acridinium compounds have high emission efficiency and stability and, hence, are useful as chemiluminescence labelling agents.
辛蒽醌化合物由一般式(I)表示,其中A是一个中间基团,不具有与特定结合物质结合的活性,Z是一个标记活性基团,具有与特定结合物质结合的活性,R.sup.1是卤素原子、烷基或芳基;R.sup.2、R.sup.3、R.sup.4和R.sup.5分别是氢原子、烷基、芳基、烷氧基、硝基、卤素原子或羰基,Y是一个对离子。 辛蒽醌化合物可以与特定结合物质形成共轭物。 辛蒽醌化合物具有高发射效率和稳定性,因此可作为化学发光标记剂。